Investigations into the physical and chemical stability of concentrated co-trimoxazole intravenous infusions

OBJECTIVES: High dose of intravenous sulfamethoxazole and trimethoprim (co-trimoxazole) is often used in immunocompromised patients for the treatment of Pneumocystis jiroveci pneumonia. Current manufacturer’s dilution recommendation for intravenous co-trimoxazole (1:25 v/v) requires the administrati...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Eur J Hosp Pharm
Asıl Yazarlar: Khaleel, Israa, Zaidi, Syed Tabish R, Shastri, Madhur D, Eapen, Mathew Suji, Ming, Long Chiau, Wanandy, Troy, Patel, Rahul P
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2018
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6319416/
https://ncbi.nlm.nih.gov/pubmed/31157078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2017-001225
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller